Correlation Between Tyra Biosciences and Entrada Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tyra Biosciences and Entrada Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tyra Biosciences and Entrada Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tyra Biosciences and Entrada Therapeutics, you can compare the effects of market volatilities on Tyra Biosciences and Entrada Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tyra Biosciences with a short position of Entrada Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tyra Biosciences and Entrada Therapeutics.

Diversification Opportunities for Tyra Biosciences and Entrada Therapeutics

-0.47
  Correlation Coefficient

Very good diversification

The 3 months correlation between Tyra and Entrada is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Tyra Biosciences and Entrada Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entrada Therapeutics and Tyra Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tyra Biosciences are associated (or correlated) with Entrada Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entrada Therapeutics has no effect on the direction of Tyra Biosciences i.e., Tyra Biosciences and Entrada Therapeutics go up and down completely randomly.

Pair Corralation between Tyra Biosciences and Entrada Therapeutics

Given the investment horizon of 90 days Tyra Biosciences is expected to under-perform the Entrada Therapeutics. In addition to that, Tyra Biosciences is 1.84 times more volatile than Entrada Therapeutics. It trades about -0.29 of its total potential returns per unit of risk. Entrada Therapeutics is currently generating about 0.19 per unit of volatility. If you would invest  1,699  in Entrada Therapeutics on August 26, 2024 and sell it today you would earn a total of  181.00  from holding Entrada Therapeutics or generate 10.65% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Tyra Biosciences  vs.  Entrada Therapeutics

 Performance 
       Timeline  
Tyra Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tyra Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Entrada Therapeutics 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Entrada Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating fundamental indicators, Entrada Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.

Tyra Biosciences and Entrada Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tyra Biosciences and Entrada Therapeutics

The main advantage of trading using opposite Tyra Biosciences and Entrada Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tyra Biosciences position performs unexpectedly, Entrada Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entrada Therapeutics will offset losses from the drop in Entrada Therapeutics' long position.
The idea behind Tyra Biosciences and Entrada Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Money Managers
Screen money managers from public funds and ETFs managed around the world